Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event
|
journal
|
December 2003 |
Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression
|
journal
|
December 2009 |
Virus Infection Triggers SUMOylation of IRF3 and IRF7, Leading to the Negative Regulation of Type I Interferon Gene Expression
|
journal
|
July 2008 |
DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells
|
journal
|
January 2003 |
Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola
|
journal
|
June 2006 |
Nitric Oxide Induces Cell Death by Regulating Anti-Apoptotic BCL-2 Family Members
|
journal
|
September 2009 |
Mechanisms of type-I- and type-II-interferon-mediated signalling
|
journal
|
May 2005 |
Evaluation of Immune Globulin and Recombinant Interferon‐α2b for Treatment of Experimental Ebola Virus Infections
|
journal
|
February 1999 |
Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence
|
journal
|
February 2006 |
Response to Imported Case of Marburg Hemorrhagic Fever, the Netherlands
|
journal
|
August 2009 |
Haematological, Biochemical and Coagulation Changes in Mice, Guinea-pigs and Monkeys Infected with a Mouse-adapted Variant of Ebola Zaire Virus
|
journal
|
November 2001 |
Forty Years of Marburg Virus
|
journal
|
November 2007 |
A Novel Immunohistochemical Assay for the Detection of Ebola Virus in Skin: Implications for Diagnosis, Spread, and Surveillance of Ebola Hemorrhagic Fever
|
journal
|
February 1999 |
Marburgvirus Hijacks Nrf2-Dependent Pathway by Targeting Nrf2-Negative Regulator Keap1
|
journal
|
March 2014 |
Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity
|
journal
|
December 1997 |
Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells
|
journal
|
April 2004 |
Infectious Lassa Virus, but Not Filoviruses, Is Restricted by BST-2/Tetherin
|
journal
|
August 2010 |
Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats
|
journal
|
July 2009 |
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.
|
journal
|
April 1996 |
Anti-Tetherin Activities of HIV-1 Vpu and Ebola Virus Glycoprotein Do Not Involve Removal of Tetherin from Lipid Rafts
|
journal
|
March 2012 |
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
|
journal
|
December 2003 |
PACT, a protein activator of the interferon-induced protein kinase, PKR
|
journal
|
August 1998 |
Structure of the Ebola VP35 interferon inhibitory domain
|
journal
|
January 2009 |
Crystal Structure of Marburg Virus VP24
|
journal
|
February 2014 |
Molecular Basis for Ebolavirus VP35 Suppression of Human Dendritic Cell Maturation
|
journal
|
August 2014 |
The Lack of Maturation of Ebola Virus-Infected Dendritic Cells Results from the Cooperative Effect of at Least Two Viral Domains
|
journal
|
April 2013 |
Modular Structure of PACT: Distinct Domains for Binding and Activating PKR
|
journal
|
March 2001 |
Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein
|
journal
|
January 2009 |
The Ebola virus VP35 protein functions as a type I IFN antagonist
|
journal
|
October 2000 |
Depletion of Peripheral Blood T Lymphocytes and NK Cells During the Course of Ebola Hemorrhagic Fever in Cynomolgus Macaques
|
journal
|
September 2004 |
Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment
|
journal
|
February 2015 |
Effects of Ebola Virus Glycoproteins on Endothelial Cell Activation and Barrier Function
|
journal
|
July 2005 |
Cell Adhesion Promotes Ebola Virus Envelope Glycoprotein-Mediated Binding and Infection
|
journal
|
April 2008 |
Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis
|
journal
|
October 2010 |
Molecular Determinants of Ebola Virus Virulence in Mice
|
journal
|
January 2006 |
An Upstream Open Reading Frame Modulates Ebola Virus Polymerase Translation and Virus Replication
|
journal
|
January 2013 |
Amino Acid Residue at Position 79 of Marburg Virus VP40 Confers Interferon Antagonism in Mouse Cells
|
journal
|
April 2015 |
Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
|
journal
|
August 2011 |
VP24 Is a Molecular Determinant of Ebola Virus Virulence in Guinea Pigs
|
journal
|
November 2011 |
Host Response Dynamics Following Lethal Infection of Rhesus Macaques With Zaire ebolavirus
|
journal
|
November 2011 |
Isolation and Partial Characterisation of a new Virus Causing Acute HÆMorrhagic Fever in Zaire
|
journal
|
March 1977 |
Mutual Antagonism between the Ebola Virus VP35 Protein and the RIG-I Activator PACT Determines Infection Outcome
|
journal
|
July 2013 |
Ebola and Marburg Viruses Replicate in Monocyte‐Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation
|
journal
|
December 2003 |
Ebola Virion Attachment and Entry into Human Macrophages Profoundly Effects Early Cellular Gene Expression
|
journal
|
October 2011 |
5 1-Integrin controls ebolavirus entry by regulating endosomal cathepsins
|
journal
|
April 2009 |
Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection
|
journal
|
October 2012 |
The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide
|
journal
|
October 2009 |
Molecular Characterization of Guinea Pig-Adapted Variants of Ebola Virus
|
journal
|
November 2000 |
The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway
|
journal
|
March 2014 |
Studies of Reservoir Hosts for Marburg Virus
|
journal
|
December 2007 |
Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
|
journal
|
February 2000 |
Structural and Functional Characterization of Reston Ebola Virus VP35 Interferon Inhibitory Domain
|
journal
|
June 2010 |
Preliminary report: isolation of Ebola virus from monkeys imported to USA
|
journal
|
March 1990 |
The Double-Stranded RNA-Binding Protein PACT Functions as a Cellular Activator of RIG-I to Facilitate Innate Antiviral Response
|
journal
|
April 2011 |
Virological and Serological Findings in Rousettus aegyptiacus Experimentally Inoculated with Vero Cells-Adapted Hogan Strain of Marburg Virus
|
journal
|
September 2012 |
The Ebola Virus VP24 Protein Prevents hnRNP C1/C2 Binding to Karyopherin α1 and Partially Alters its Nuclear Import
|
journal
|
November 2011 |
The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein
|
journal
|
April 2008 |
Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis
|
journal
|
November 2011 |
Studies of Ebola Virus Glycoprotein-Mediated Entry and Fusion by Using Pseudotyped Human Immunodeficiency Virus Type 1 Virions: Involvement of Cytoskeletal Proteins and Enhancement by Tumor Necrosis Factor Alpha
|
journal
|
December 2004 |
Filovirus replication and transcription
|
journal
|
March 2007 |
Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway
|
journal
|
November 2008 |
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
|
journal
|
January 2008 |
RIG-I activation inhibits ebolavirus replication
|
journal
|
September 2009 |
Human Ebola virus infection results in substantial immune activation
|
journal
|
March 2015 |
Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro
|
journal
|
July 2007 |
The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin
|
journal
|
November 2011 |
Structural basis for Marburg virus VP35-mediated immune evasion mechanisms
|
journal
|
November 2012 |
Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus
|
journal
|
December 2012 |
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
|
journal
|
August 2014 |
Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1
|
journal
|
August 2014 |
A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding
|
journal
|
November 2000 |
Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection
|
journal
|
June 2005 |
Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells
|
journal
|
January 2011 |
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
|
journal
|
August 2011 |
Basic Residues within the Ebolavirus VP35 Protein Are Required for Its Viral Polymerase Cofactor Function
|
journal
|
August 2010 |
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages.
|
journal
|
January 1996 |
A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus
|
journal
|
October 2004 |
Filovirus assembly and budding
|
journal
|
January 2006 |
The VP40 Protein of Marburg Virus Exhibits Impaired Budding and Increased Sensitivity to Human Tetherin following Mouse Adaptation
|
journal
|
October 2014 |
Phosphatidylserine receptors: Enhancers of enveloped virus entry and infection
|
journal
|
November 2014 |
Lymphocyte Death in a Mouse Model of Ebola Virus Infection
|
journal
|
November 2007 |
Ebola Virus Selectively Inhibits Responses to Interferons, but Not to Interleukin-1β, in Endothelial Cells
|
journal
|
April 1999 |
ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity
|
journal
|
February 2008 |
Emerging and reemerging of filoviruses
|
book
|
January 1996 |
Ebola Zaire Virus Blocks Type I Interferon Production by Exploiting the Host SUMO Modification Machinery
|
journal
|
June 2009 |
The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
|
journal
|
February 2012 |
Dendritic Cells
|
journal
|
August 2001 |
Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
|
journal
|
March 2003 |
Ebola Virus Glycoprotein Counteracts BST-2/Tetherin Restriction in a Sequence-Independent Manner That Does Not Require Tetherin Surface Removal
|
journal
|
May 2010 |
Markedly Elevated Levels of Interferon (IFN)‐σ, IFN‐α, Interleukin (IL)‐2, IL‐10, and Tumor Necrosis Factor‐α Associated with Fatal Ebola Virus Infection
|
journal
|
February 1999 |
The role of the Type I interferon response in the resistance of mice to filovirus infection
|
journal
|
June 2001 |
Transmission of Ebola Hemorrhagic Fever: A Study of Risk Factors in Family Members, Kikwit, Democratic Republic of the Congo, 1995
|
journal
|
February 1999 |
Human Infection Due to Ebola Virus, Subtype Côte d'Ivoire: Clinical and Biologic Presentation
|
journal
|
February 1999 |
Discovery of an Ebolavirus-Like Filovirus in Europe
|
journal
|
October 2011 |
Ebola Virus Inhibits Induction of Genes by Double-Stranded RNA in Endothelial Cells
|
journal
|
December 1998 |
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
|
journal
|
April 1999 |
ORAL SHEDDING OF MARBURG VIRUS IN EXPERIMENTALLY INFECTED EGYPTIAN FRUIT BATS ( ROUSETTUS AEGYPTIACUS )
|
journal
|
January 2015 |
Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses
|
journal
|
May 1998 |
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
|
journal
|
February 1999 |
Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury
|
journal
|
August 2000 |
Key Genomic Changes Necessary for an In Vivo Lethal Mouse Marburgvirus Variant Selection Process
|
journal
|
February 2011 |
Genomic Differences between Guinea Pig Lethal and Nonlethal Marburg Virus Variants
|
journal
|
November 2007 |
Reston ebolavirus in Humans and Animals in the Philippines: A Review
|
journal
|
November 2011 |
Pathogenesis of Ebola Hemorrhagic Fever in Primate Models
|
journal
|
December 2003 |
Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner
|
journal
|
September 2010 |
Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin
|
journal
|
November 2008 |
Ebola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer
|
journal
|
June 2001 |
Functional CD8 + T Cell Responses in Lethal Ebola Virus Infection
|
journal
|
March 2008 |
An Interferon-α-Induced Tethering Mechanism Inhibits HIV-1 and Ebola Virus Particle Release but Is Counteracted by the HIV-1 Vpu Protein
|
journal
|
September 2007 |
Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes
|
journal
|
September 2010 |
Epidemiologic Investigation of Marburg Virus Disease, Southern Africa, 1975 *
|
journal
|
November 1978 |
Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35
|
journal
|
January 2010 |
Development of a model for marburgvirus based on severe-combined immunodeficiency mice
|
journal
|
January 2007 |
The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3
|
journal
|
July 2003 |
Evasion of Interferon Responses by Ebola and Marburg Viruses
|
journal
|
September 2009 |
Emergence of Zaire Ebola Virus Disease in Guinea
|
journal
|
October 2014 |
Interferon-stimulated genes: roles in viral pathogenesis
|
journal
|
June 2014 |
Viral immune modulators perturb the human molecular network by common and unique strategies
|
journal
|
July 2012 |
Marburg Virus Infection Detected in a Common African Bat
|
journal
|
August 2007 |
Marburg Hemorrhagic Fever Associated with Multiple Genetic Lineages of Virus
|
journal
|
August 2006 |
Interferon-Stimulated Genes: A Complex Web of Host Defenses
|
journal
|
March 2014 |
Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism
|
journal
|
September 2012 |
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
|
journal
|
January 2011 |
Mechanisms and Consequences of Ebolavirus-Induced Lymphocyte Apoptosis
|
journal
|
December 2009 |
Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus
|
journal
|
January 2010 |
The Tyro3 Receptor Kinase Axl Enhances Macropinocytosis of Zaire Ebolavirus
|
journal
|
November 2010 |
Coping with stress: eIF2 kinases and translational control
|
journal
|
January 2006 |
Tyro3 Family-Mediated Cell Entry of Ebola and Marburg Viruses
|
journal
|
September 2006 |
Inflammatory responses in Ebola virus-infected patients
|
journal
|
April 2002 |
Monocyte-Derived Human Macrophages and Peripheral Blood Mononuclear Cells Infected with Ebola Virus Secrete MIP-1α and TNF-α and Inhibit Poly-IC-Induced IFN-α in Vitro
|
journal
|
May 2001 |
The Keap1–Nrf2 Cell Defense Pathway – A Promising Therapeutic Target?
|
book
|
January 2012 |
Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein
|
journal
|
October 2005 |
The Ins and Outs of STAT1 Nuclear Transport
|
journal
|
August 2003 |